Aspira Pathlab & Diagnostics Ltd — Important, 13-10-2025: Company Update

Aspira Pathlab & Diagnostics has received an open offer from a group of acquirers, led by Mr. Arvind Karsandas Bhanushali, to acquire up to 26.76 lakh equity shares. This represents 26% of the company's total voting capital, at a price of ₹55 per share in cash, totaling up to ₹14.72 Cr. The offer aims to consolidate promoter holdings and will result in a change of control. After the offer, the acquirers will hold 49.82% of the shares. The company's independent directors will provide their view to public shareholders, who can tender their shares via the stock exchange. The acquirers confirm adequate internal financial resources for the offer.